Rosuvastatin Completed Phase 4 Trials for Systemic Lupus Erythematosus (SLE) / Thromboembolism / Atherosclerosis Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00371501Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus